Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)

European Journal of Cancer

Volumn 39, Issue 4, 2003, Pages 481-487

  Van Rijswijk, R E N ^a   Vermorken, J B ^b   Reed, N ^c   Favalli, G ^d   Mendiola, C ^e   Zanaboni, F ^o   Mangili, G ^f   Vergote, I ^g   Guastalla, J P ^h   Ten Bokkel Huinink, W W ⁱ   Lacave, A J ^j   Bonnefoi, H ^k   Tumulo, S ^l   Rietbroek, R ^m   Teodorovic, I ⁿ   Coens, C ⁿ   Pecorelli, S ^d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^d UNIVERSITY OF BRESCIA   (Italy)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h CENTRE LÉON BÉRARD   (France)

ⁱ NETHERLANDS CANCER INSTITUTE   (Netherlands)

^j HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^k GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^l CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^m ACADEMIC MEDICAL CENTER   (Netherlands)

ⁿ EORTC DATA CENTER   (Belgium)

^o NONE

more..

Author keywords

Carcinosarcoma; Cisplatin; Doxorubicin; Gynaecological cancer; Ifosfamide; Phase II

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE; MESNA; PLATINUM;

ADULT; AGED; ALOPECIA; ARTICLE; BLEEDING; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER RESEARCH; CANCER SURVIVAL; CARCINOSARCOMA; CARDIOTOXICITY; CHEMOSENSITIVITY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; FEMALE; FEMALE GENITAL TRACT CANCER; FEVER; HUMAN; LAPAROTOMY; LEUKOPENIA; NEPHROTOXICITY; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOSARCOMA; CISPLATIN; DOXORUBICIN; FEMALE; GENITAL NEOPLASMS, FEMALE; HEMATOLOGIC DISEASES; HUMANS; IFOSFAMIDE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0037366079     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00740-2     Document Type: Article

References (38)

1. Solis O.G., Bui H.X., Malfetano J.H., Ross J.S. Extragenital primary mixed malignant mesodermal tumor. Gynecol. Oncol. 43:1991;182-185.
2. Garde J.R., Jones M.A., McAfee R., Tarraza H.M. Extragenital malignant mixed mullerian tumor. review of the literature Gynecol Oncol. 43:1991;186-190.
3. Muntz H.G., Rutgers J., Tarraza H.M., Fuller A.F. Carcinosarcomas and mixed Mullerian tumors of the fallopian tube. Gynecol. Oncol. 34:1989;109-115.
4. George M., Pejovic M.H., Kramar A. Uterine sarcomas. prognostic factors and treatment modalities - study on 209 patients Gynecol. Oncol. 24:1986;58-67.
5. Nielsen S.N., Podratz K.C., Scheithauer B.W., O'Brien P.C. Clinicopathologic analysis of uterine malignant mixed mullerian tumors. Gynecol. Oncol. 34:1989;372-378.
6. Podczaski E.S., Woomert C.A., Stevens C.W. Jr. Management of malignant mixed mesodermal tumors of the uterus. Gynecol. Oncol. 32:1989;240-244.
7. Chang J., Sharpe J.C., A'Hern R.P.et al. Carcinosarcoma of the ovary. incidence, prognosis, treatment and survival of patients Ann. Oncol. 6:1995;755-758.
8. Hanjani P., Petersen R.O., Lipton S.E., Nolte S.A. Malignant mixed mesodermal tumors and carcinosarcomas of the ovary. report of 8 cases and review of the literature Obstet. Gynecol. Surv. 38:1983;537-545.
9. Dinh T.V., Slavin R.E., Bhagavan B.S.et al. Mixed mesodermal tumors of the ovary. a clinicopathologic study of 14 cases Obstet. Gynecol. 72:1988;409-412.
10. Suggs C.L.3d, Lee J.L. Jr., Choi H., Lewis G.C. Malignant mixed mesodermal tumors of the ovary. A report of 13 cases. Am. J. Clin. Oncol. 11:1988;12-15.
11. Plaxe S.C., Dottino P.R., Goodman H.M.et al. Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapy. Gynecol. Oncol. 37:1990;244-249.
12. Terada K.Y., Johnson T.L., Hopkins M., Roberts J.A. Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas. Gynecol. Oncol. 32:1989;228-232.
13. Andersen W.A., Young D.E., Peters W.A. 3det al. Platinum-based combination chemotherapy for malignant mixed mesodermal tumors of the ovary. Gynecol. Oncol. 32:1989;319-322.
14. Muntz H.G., Jones M.A., Goff B.A.et al. Malignant mixed mullerian tumors of the ovary. experience with surgical cytoreduction and combination chemotherapy Cancer. 76:1995;1209-1213.
15. Meis J.M., Lawrence W.D. The immunohistochemical profile of malignant mixed mullerian tumor. Am. J. Clin. Pathol. 94:1990;1-7.
16. Bitterman P., Chun B., Kurman R.J. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study. Am. J. Surg. Pathol. 14:1990;317-328.
17. Noorduyn L.A., Herman C.J. The relation between mixed mesodermal tumors and adenocarcinomas of the ovary. an immunopathologic study Eur. J. Cancer Clin. Oncol. 23:1987;157-162.
18. Silverberg S.G., Major F.J., Blessing J.A.et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int. J. Gynecol. Pathol. 9:1990;1-19.
19. Deligdisch L., Plaxe S., Cohen C.J. Extrauterine pelvic malignant mixed mesodermal tumors. A study of 10 cases with immunohistochemistry. Int. J. Gynecol. Pathol. 7:1988;361-372.
20. Bramwell V.H., Mouridsen H.T., Santoro A.et al. Cyclophosphamide versus ifosfamide. final report of a randomized phase II trial in adult soft tissue sarcomas Eur. J. Cancer Clin. Oncol. 23:1987;311-321.
21. Sutton G.P., Blessing J.A., Rosenshein N.et al. Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study). Am. J. Obstet. Gynecol. 161:1989;309-312.
22. Peters W.A. 3d, Rivkin S.E., Smith M.R., Tesh D.E. Cisplatin and adriamycin combination chemotherapy for uterine stromal sarcomas and mixed mesodermal tumors. Gynecol. Oncol. 34:1989;323-327.
23. van Rijswijk R.E.N., Tognon G., Burger C.W.et al. The effect of chemotherapy on the components of advanced carcinosarcomas (malig-nant mixed mesodermmal tumors) of the female genital tract. Int. J. Gynecol. Cancer. 4:1994;52-60.
24. Marchese M.J., Liskow A.S., Crum C.P.et al. Uterine sarcomas. a clinicopathologic study Gynecol. Oncol. 18:1984;293-298.
25. Morrow C.P., d'Ablaing G., Brady L.W.et al. A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors. a Gynecologic Oncology Group study Gynecol. Oncol. 18:1984;278-292.
26. Perez C.A., Askin F., Baglan R.J.et al. Effects of irradiation on mixed mullerian tumors of the uterus. Cancer. 43:1979;1274-1279.
27. Peters W.A., Kumar N.B., Fleming W.P., Morley G.W. Prognostic features of sarcomas and mixed tumors of the endometrium. Obstet. Gynecol. 63:1984;550-556.
28. Chiara S., Foglia G., Odicino F.et al. Uterine sarcomas. a clinicopathologic study Oncology. 45:1988;428-433.
29. Hajnal-Papp R., Szilagyi I. Malignant mullerian tumours of the uterus. Arch. Gynecol. Obstet. 241:1988;209-219.
30. Sood A.K., Sorosky J.I., Gelder M.S.et al. Primary ovarian sarcoma. Analysis of variables and the role of surgical reduction. Cancer. 82:1998;1731-1737.
31. Spanos W.J., Peters L.J., Oswald M.J. Patterns of recurrence in malignant mixed mullerian tumor of the uterus. Cancer. 57:1986;155-159.
32. Kohorn E.I., Schwartz P.E., Chambers J.T.et al. Adjuvant therapy in mixed Mullerian tumors of the uterus. Gynecol. Oncol. 23:1986;212-221.
33. Salazar O.M., Bonfiglio T.A., Patten S.F.et al. Uterine sarcomas. Analysis of failures with special emphasis on the use of adjuvant radiotherapy. Cancer. 42:1978;1161-1170.
34. Omura G.A., Blessing J.A., Major F.et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas. a Gynecologic Oncology Group study J. Clin. Oncol. 9:1985;1240-1245.
35. Manolitsas T.P., Wain G.V., Williams K.E.et al. Multimodality therapy for patients with clinical stage I and II malignant mixed Müllerian tumors of the uterus. Cancer. 91:2001;1437-1443.
36. Sutton G., Brunetto V.L., Kilgore L.et al. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus. a Gynecologic Oncology Group study Gynecol. Oncol. 79:2000;147-153.
37. Bicher A., Levenback C., Silva E.G.et al. Ovarian malignant mixed mullerian tumors treated with platinum-based chemotherapy. Obstet. Gynecol. 85:1995;735-739.
38. Sit A.S.Y., Price F.V., Kelley J.L.et al. Chemotherapy for malignant mixed Mullerian tumors of the ovary. Gynecol. Oncol. 79:2000;196-200.